Key Players
Competitive Landscape
Supplier competition across the starches/glucose landscape spans Tier 1 multi-crop wet-milling biorefiners, Tier 2 industrial enzyme fermenters, and Tier 3 sweetness and flavor modulation houses. Starch refining leaders Cargill, ADM Tate & Lyle and Roquette operate high-throughput corn cassava with potato and pea wet-mills. Biotech leaders novonesis and dsm-firmenich enzyme specialists supply thermostable alpha-amylases, glucoamylases and glucose isomerases while Givaudan and Symrise supply taste modulators that balance reduced-DE syrup formulations.
Reallocation of wet-milling grind capacity from commodity bulk syrups into clean-label texturizing starches and over-the-fence bio-fermentation dextrose represents the decisive margin driver for market leaders. At the same time, enzyme and flavor partners co-develop low-pH liquefaction cascades and sweetness restitution systems for sugar-taxed markets. In September 2026, Cargill documented its APAC modified food starch with sweetener and texturizer solutions at Fi Asia 2026 and demonstrating how clean-label tapioca and waxy corn starches improve mouthfeel in low-sugar formulations. Meanwhile, in August 2026, Archer Daniels Midland Company reported second-quarter 2026 results detailing resilient Carbohydrate Solutions cash flow and USD 1.3 billion to USD 1.5 billion in capital expenditure guidance.
Company developments mapped to drivers, trends and opportunities (2026 to 2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| November 2024: Tate & Lyle completed its combination with CP Kelco to create a specialty texturizer leader. | Food processors require integrated starch, pectin, and hydrocolloid mouthfeel systems. | Refiners divest commodity bulk syrups and acquire specialty texturizer portfolios. | Cross-selling clean-label CLARIA starches with CP Kelco pectins expands gross margins. |
| May 2025: Roquette completed its acquisition of IFF Pharma Solutions. | Pharmaceutical and bio-fermentation sectors demand high-purity starch excipients and dextrose. | Biorefiners integrate upstream wheat/corn starch extraction with downstream pharma polymers. | Locks in high-margin pharmaceutical tablet binder and parenteral dextrose contracts. |
| December 2025: Novonesis launched Termamyl Prime alpha-amylase for high-gravity liquefaction. | Starch refineries and breweries face variable grain quality and high evaporator energy costs. | Enzyme leaders engineer low-pH calcium-independent amylases and pullulanases. | Boosts high-gravity syrup throughput while cutting ion-exchange chemical usage by 30%. |
| September 2026: Cargill showcased modified food starch and low-sugar texturizer solutions at Fi Asia 2026. | Asian and global consumers seek low-sugar foods with indulgent creamy mouthfeel. | Wet-millers co-formulate tapioca and waxy maize starches with sweetness modulators. | Captures premium pricing across dairy, bakery, and culinary sauce accounts in Asia-Pacific. |
Source: Future Market Insights, Starches/Glucose Market Report, 2026 to 2036.
Recent M&A combinations and specialty starch plant investments confirm that winning multi-year CPG and industrial accounts in the starches/glucose market requires combining clean-label physical modification with multi-hydrocolloid formulation support. Refiners that pair hydrothermal waxy corn and tapioca starches with enzymatic sugar-reduction syrups are projected to capture superior margin growth through 2036.
How are key market participants positioned in the starches/glucose market?
Cargill and ADM as well as Ingredion, Tate & Lyle and Roquette lead in physical grain wet-milling with modified food starches and bulk glucose/HFCS supply. biotech suppliers novonesis and dsm-firmenich lead in enzymatic starch liquefaction and isomerization, while Givaudan and Symrise lead in sweetness and mouthfeel modulation.
What qualification or purchasing requirements matter most to prospective buyers?
Beverage, confectionery and paperboard procurement directors require tight Dextrose Equivalent (DE) and ash tolerances with verified UHT shear and freeze-thaw syneresis curves with non-GMO or clean-label ingredient declarations and heated railcar or bulk silo delivery reliability.
Which product or application capabilities distinguish the leading companies?
Starch wet-milling leaders differentiate through patented hydrothermal physical starch modification (such as Ingredion NOVATION and Tate & Lyle CLARIA) and pea/tapioca botanical diversity, whereas Novonesis differentiates through calcium-independent alpha-amylases and immobilized glucose isomerase column longevity.
How does geographic reach differ among the key market players?
Cargill, ADM and Ingredion anchor North and South American corn and tapioca refining as well as Asian hubs with Roquette leads European wheat/potato and Canadian pea biorefining with Tate & Lyle leads global specialty texturizers and Novonesis as well as DSM-Firmenich with Givaudan and Symrise serve refineries and CPG plants globally.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Novonesis | Global biosolutions leader supplying Termamyl and Liquozyme alpha-amylases, Spirizyme glucoamylases, and Sweetzyme isomerases. | Launched Termamyl Prime liquefaction biosolution in December 2025 and Optiva LS Prime in June 2025. |
| Givaudan SA | Global Taste & Wellbeing leader supplying natural sweetness enhancers and mouthfeel modulators for reduced-glucose beverages. | Reported H1 2026 and 9M 2026 results in July and October 2026 highlighting beverage taste modulation growth. |
| Symrise AG | Global Taste, Nutrition & Health supplier manufacturing SymLife Sweet masking and viscosity perception systems. | Reported strong Q3 2026 organic sales growth in October 2026 led by Food & Beverage Naturals and Sweet segments. |
| Chr. Hansen Holding AS | Global microbial biosolutions pioneer merged with Novozymes in January 2024 to establish Novonesis. | Integrated dairy, beverage, and fermentation culture platforms with industrial starch-processing enzymes. |
| DSM-Firmenich AG | Global nutrition and bioscience group supplying starch-processing enzymes, hydrocolloids, and TasteGEM modulators. | Unveiled major Taste, Texture & Health plant investments in August 2025 to expand clean-label ingredient capacity. |
| Cargill Incorporated | Global wet-milling powerhouse producing C*Gel native starches, C*PolarTex modified starches, SimPure clean-label, and HFCS. | Highlighted APAC modified food starch, sweetener, and texturizer solutions at Fi Asia in September 2026. |
| Archer Daniels Midland Company | Global agricultural processor operating mega-scale Corn Belt wet-mills producing HFCS, Clintose glucose, and corrugated starches. | Reported Q2 2026 results in August 2026 with USD 1.3B to USD 1.5B CapEx guidance and growing Biosolutions fermentation feedstocks. |
| Ingredion Incorporated | Global specialty starch leader producing NOVATION clean-label native starches and PURITY modified food starches. | Expanded NOVATION PRIMA freeze-thaw stable clean-label corn and tapioca starch lines across global food accounts in 2025. |
| Tate & Lyle PLC | Global specialty food and beverage solutions provider supplying CLARIA clean-label starches and PROMITOR fibers. | Completed combination with CP Kelco on November 15, 2024 to unite specialty starches with pectin and gums. |
| Roquette Freres | Global multi-crop biorefiner processing wheat, maize, potato, and Canadian yellow pea into starches, glucose, and pharma dextrose. | Completed acquisition of IFF Pharma Solutions on May 1, 2025 to expand pharmaceutical starch and excipient reach. |
Research Methodology
Triangulation of the starches/glucose market combined primary interviews with wet-milling refinery directors, enzymatic bioprocess engineers, and CPG procurement heads as well as official agricultural grind balances. Physical dry-basis shipment volumes (0.112 billion metric tons in 2026) were reconciled against bulk tanker syrup and specialty modified starch contract ASP realizations. Final valuation figures represent a 4.9% child share of the Global Food and Specialty Ingredients Industry benchmark with compounding validated at 2.8% CAGR and zero hierarchy anomalies.